TRAF3IP2 and Autoimmunity: Based on these findings, we propose that while Act1 is a necessary signaling molecule for IL-17 signaling, Act1 serves as a negative regulator to modulate Th17-B cell interaction via its impact on IL-23/IL-21/STAT3 axis and CD40, thereby controlling autoimmunity (Supplementary Fig. 5).